Oct 28, 2026 4:30pm EDT LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession
Oct 22, 2026 8:00am EDT LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
Aug 11, 2026 4:05pm EDT LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Aug 04, 2026 4:05pm EDT LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
Jul 06, 2026 8:15am EDT LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia
Jun 24, 2026 8:30am EDT LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
Jun 07, 2026 7:30pm EDT LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
May 11, 2026 4:05pm EDT LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 04, 2026 8:00am EDT LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference